The Netherlands

In a rare example of a university tec transfer deal attracting an upfront payment, French pharma company Ipsen paying €1.25 million for a treatment licence.

Anglo-Dutch antibody specialist PanGenetics BV has agreed a collaboration with Lay Line Genomics SpA of Rome, Italy, in the field of therapeutic antibodies for the treatment of pain.